242 related articles for article (PubMed ID: 33057033)
1. Osteocyte Vegf-a contributes to myeloma-associated angiogenesis and is regulated by Fgf23.
Mulcrone PL; Edwards SKE; Petrusca DN; Haneline LS; Delgado-Calle J; Roodman GD
Sci Rep; 2020 Oct; 10(1):17319. PubMed ID: 33057033
[TBL] [Abstract][Full Text] [Related]
2. Bidirectional Notch Signaling and Osteocyte-Derived Factors in the Bone Marrow Microenvironment Promote Tumor Cell Proliferation and Bone Destruction in Multiple Myeloma.
Delgado-Calle J; Anderson J; Cregor MD; Hiasa M; Chirgwin JM; Carlesso N; Yoneda T; Mohammad KS; Plotkin LI; Roodman GD; Bellido T
Cancer Res; 2016 Mar; 76(5):1089-100. PubMed ID: 26833121
[TBL] [Abstract][Full Text] [Related]
3. Prostate cancer promotes a vicious cycle of bone metastasis progression through inducing osteocytes to secrete GDF15 that stimulates prostate cancer growth and invasion.
Wang W; Yang X; Dai J; Lu Y; Zhang J; Keller ET
Oncogene; 2019 Jun; 38(23):4540-4559. PubMed ID: 30755731
[TBL] [Abstract][Full Text] [Related]
4. JunB is a key regulator of multiple myeloma bone marrow angiogenesis.
Fan F; Malvestiti S; Vallet S; Lind J; Garcia-Manteiga JM; Morelli E; Jiang Q; Seckinger A; Hose D; Goldschmidt H; Stadlbauer A; Sun C; Mei H; Pecherstorfer M; Bakiri L; Wagner EF; Tonon G; Sattler M; Hu Y; Tassone P; Jaeger D; Podar K
Leukemia; 2021 Dec; 35(12):3509-3525. PubMed ID: 34007044
[TBL] [Abstract][Full Text] [Related]
5. Myeloma cell-osteoclast interaction enhances angiogenesis together with bone resorption: a role for vascular endothelial cell growth factor and osteopontin.
Tanaka Y; Abe M; Hiasa M; Oda A; Amou H; Nakano A; Takeuchi K; Kitazoe K; Kido S; Inoue D; Moriyama K; Hashimoto T; Ozaki S; Matsumoto T
Clin Cancer Res; 2007 Feb; 13(3):816-23. PubMed ID: 17289872
[TBL] [Abstract][Full Text] [Related]
6. [Link between osteoclastogenesis, angiogenesis and myeloma expansion].
Abe M
Clin Calcium; 2008 Apr; 18(4):473-9. PubMed ID: 18379029
[TBL] [Abstract][Full Text] [Related]
7. Osteocyte-induced angiogenesis via VEGF-MAPK-dependent pathways in endothelial cells.
Prasadam I; Zhou Y; Du Z; Chen J; Crawford R; Xiao Y
Mol Cell Biochem; 2014 Jan; 386(1-2):15-25. PubMed ID: 24162672
[TBL] [Abstract][Full Text] [Related]
8. Osteocytes control myeloid cell proliferation and differentiation through Gsα-dependent and -independent mechanisms.
Azab E; Chandler KB; Uda Y; Sun N; Hussein A; Shuwaikan R; Lu V; Costello CE; McComb ME; Divieti Pajevic P
FASEB J; 2020 Aug; 34(8):10191-10211. PubMed ID: 32557809
[TBL] [Abstract][Full Text] [Related]
9. Bone marrow angiogenic ability and expression of angiogenic cytokines in myeloma: evidence favoring loss of marrow angiogenesis inhibitory activity with disease progression.
Kumar S; Witzig TE; Timm M; Haug J; Wellik L; Kimlinger TK; Greipp PR; Rajkumar SV
Blood; 2004 Aug; 104(4):1159-65. PubMed ID: 15130943
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of Syndecan-1 in the bone marrow microenvironment in multiple myeloma is associated with angiogenesis.
Andersen NF; Kristensen IB; Preiss BS; Christensen JH; Abildgaard N
Eur J Haematol; 2015 Sep; 95(3):211-7. PubMed ID: 25353275
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow neovascularization, plasma cell angiogenic potential, and matrix metalloproteinase-2 secretion parallel progression of human multiple myeloma.
Vacca A; Ribatti D; Presta M; Minischetti M; Iurlaro M; Ria R; Albini A; Bussolino F; Dammacco F
Blood; 1999 May; 93(9):3064-73. PubMed ID: 10216103
[TBL] [Abstract][Full Text] [Related]
12. Homotypic and Heterotypic Activation of the Notch Pathway in Multiple Myeloma-Enhanced Angiogenesis: A Novel Therapeutic Target?
Saltarella I; Frassanito MA; Lamanuzzi A; Brevi A; Leone P; Desantis V; Di Marzo L; Bellone M; Derudas D; Ribatti D; Chiaramonte R; Palano MT; Neri A; Mariggiò MA; Fumarulo R; Dammacco F; Racanelli V; Vacca A; Ria R
Neoplasia; 2019 Jan; 21(1):93-105. PubMed ID: 30529074
[TBL] [Abstract][Full Text] [Related]
13. Lentiviral shRNA silencing of BDNF inhibits in vivo multiple myeloma growth and angiogenesis via down-regulated stroma-derived VEGF expression in the bone marrow milieu.
Zhang L; Hu Y; Sun CY; Li J; Guo T; Huang J; Chu ZB
Cancer Sci; 2010 May; 101(5):1117-24. PubMed ID: 20331634
[TBL] [Abstract][Full Text] [Related]
14. FGF23 is elevated in multiple myeloma and increases heparanase expression by tumor cells.
Suvannasankha A; Tompkins DR; Edwards DF; Petyaykina KV; Crean CD; Fournier PG; Parker JM; Sandusky GE; Ichikawa S; Imel EA; Chirgwin JM
Oncotarget; 2015 Aug; 6(23):19647-60. PubMed ID: 25944690
[TBL] [Abstract][Full Text] [Related]
15. Salidroside improves angiogenesis-osteogenesis coupling by regulating the HIF-1α/VEGF signalling pathway in the bone environment.
Guo Q; Yang J; Chen Y; Jin X; Li Z; Wen X; Xia Q; Wang Y
Eur J Pharmacol; 2020 Oct; 884():173394. PubMed ID: 32730833
[TBL] [Abstract][Full Text] [Related]
16. CCL5/CCR5 axis induces vascular endothelial growth factor-mediated tumor angiogenesis in human osteosarcoma microenvironment.
Wang SW; Liu SC; Sun HL; Huang TY; Chan CH; Yang CY; Yeh HI; Huang YL; Chou WY; Lin YM; Tang CH
Carcinogenesis; 2015 Jan; 36(1):104-14. PubMed ID: 25330803
[TBL] [Abstract][Full Text] [Related]
17. GPER mediates the angiocrine actions induced by IGF1 through the HIF-1α/VEGF pathway in the breast tumor microenvironment.
De Francesco EM; Sims AH; Maggiolini M; Sotgia F; Lisanti MP; Clarke RB
Breast Cancer Res; 2017 Dec; 19(1):129. PubMed ID: 29212519
[TBL] [Abstract][Full Text] [Related]
18. Angiogenesis in multiple myeloma.
Vacca A; Ria R; Reale A; Ribatti D
Chem Immunol Allergy; 2014; 99():180-96. PubMed ID: 24217610
[TBL] [Abstract][Full Text] [Related]
19. Bone marrow-derived mesenchymal stem cells induced by inflammatory cytokines produce angiogenetic factors and promote prostate cancer growth.
Yang KQ; Liu Y; Huang QH; Mo N; Zhang QY; Meng QG; Cheng JW
BMC Cancer; 2017 Dec; 17(1):878. PubMed ID: 29268703
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia-inducible factor (HIF)-1α suppression in myeloma cells blocks tumoral growth in vivo inhibiting angiogenesis and bone destruction.
Storti P; Bolzoni M; Donofrio G; Airoldi I; Guasco D; Toscani D; Martella E; Lazzaretti M; Mancini C; Agnelli L; Patrene K; Maïga S; Franceschi V; Colla S; Anderson J; Neri A; Amiot M; Aversa F; Roodman GD; Giuliani N
Leukemia; 2013 Aug; 27(8):1697-706. PubMed ID: 23344526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]